BMRA
$9.11
Biomerica
($.23)
(2.46%)
BMRA
Earnings Whisper ®
N/A
4th Quarter May 2020
Consensus:  ($0.05)
Revenue:  $1.52 Mil
Friday
Aug 28
8:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Wednesday, April 15, 2020

What do you expect when BMRA reports earnings?
Beat
Meet
Miss

Where is BMRA's stock price going from here?
Up
Flat
Down
Stock chart of BMRA
Analysts
Summary of analysts' recommendations for BMRA
Score
Grade
Pivots
Resistance
$10.38
$10.10
$9.61

$9.33

Support
$8.84
$8.56
$8.07
Tweet
Growth
Description
BIOMERICA, INC. is an emerging-growth biotechnology firm that develops, manufactures and distributes medical diagnostic products. The Company is focused on niche products for early detection and monitoring of human diseases and conditions before they become catastrophic and incurable. The customers include medical universities, pharmaceutical companies, hospitals, clinics, commercial laboratories, physician's offices and consumers.
Peers
DENTSPLY SIRONA